John R Leone

CIK 1301047 · last filed 2021-02-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.40M

Companies

5

Total Filings

25

Lifetime Open-Market Net

$23.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WINT Director 7,473 $0.01 $108 $15.0K 7 2021-02-05
PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Director $0 2 2018-05-23
DSCO Director 96,623 $24.82 $2.40M $8.6K 5 2015-08-18
VIROPHARMA INC (VPHM) Delisted Director 11,000 $0 7 2013-02-25
OSCIENT PHARMACEUTICALS CORP (OSCI) Delisted Director 1,389,789 $0 2 2008-06-13

Recent Filings · Page 3 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-06-13 OSCIENT PHARMACEUTICALS CORP (OSCI) Delisted Grant (A) +300 $0 EDGAR
2008-02-27 VIROPHARMA INC (VPHM) Delisted Grant (A) $0 EDGAR
2007-12-10 OSCIENT PHARMACEUTICALS CORP (OSCI) Delisted Grant (A) +600 $0 EDGAR
2007-10-24 Grant (A) $0
2007-02-28 VIROPHARMA INC (VPHM) Delisted Grant (A) $0 EDGAR
Showing 2125 of 25
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.